Beyond Parameter Counts: The Shift Toward Rigorous Evaluation in Scientific AI
Why the 'bigger is better' paradigm hits a wall in structural biology, and how modern drug discovery requires a multi-tier assessment lifecycle spanning physical grounding, generalization, developability, and live biological validation.
Jul 21, 2026